Cardiology

Latest News


CME Content


A 35-year-old man presents to the emergency department complaining of syncope. He denies any preceding chest pain, palpitations or trouble breathing, and states he did not injure himself other than a bump on his forehead.

A new tool for assessing the risk of thromboembolic events in patients with atrial fibrillation performed better than the existing standard in a large retrospective analysis. ATRIA risk scores were less likely than CHA2DS2-VASc scores to mistakenly characterize patients as "high risk" and, therefore, to lead to the overuse of anticoagulation.

The link between testosterone therapy and cardiovascular risks has been a hot topic of debate, with researchers offering competing evidence and statements supporting or refuting the existence of link between testosterone supplementation and increased cardiovascular risk. Now, physicians from the American Association of Clinical Endocrinologists (AACE) have publicly stated their position on the issue.

Cardiovascular patients are the focus of the recent drug approval by the Food and Drug Administration (FDA). Branded under the name Durlaza, the 24-hour extended-release aspirin is the first of its kind and is expected to become available before the end of the year.

A general practitioner can gain a better understanding of a patient’s underlying cardiac ailments by focusing on the fundamentals of pacemakers and automated implantable cardioverter defibrillators (AICDs).In the first part of this 3-part article (“Pacemakers and AICDs: The ABCs”), we discussed distinguishing between pacemakers and AICDs. The second part (“Pacemakers and AICDs: Nomenclature and Malfunction”) addressed pacemaker nomenclature and device function, malfunction, and pseudomalfunction. Here we cover interrogation reports and interpretation of EKGs.